

EDUCATION AND TRAINING
Fellowship, University of Washington, Department of Pathology, Seattle, WA
Ph.D., Massachusetts Institute of Technology, Applied Biological
Sciences, Boston, MA
|
|
Mary Y. Chang, Ph.D.
Research Assistant Professor
Division of Metabolism, Endocrinology and Nutrition
OFFICE ADDRESS
University of Washington School of Medicine
1959 NE Pacific Street
UW Mailbox 356426
Seattle, WA 98195-6426
CURRENT RESEARCH INTERESTS
Ongoing research focuses on atherosclerosis with an emphasis on
defining the mechanisms and consequences of lipoprotein retention in the
arterial wall. Of interest
are (i) understanding the nature of the interactions between
lipoproteins and extracellular matrix molecules, and (ii) understanding
the regulatory mechanisms by which lipoproteins modulate the synthesis
of extracellular matrix molecules by both macrophages and smooth muscle
cells. These studies
emphasize a role for factors associated with diabetes, including
hyperglycemia and lipoprotein oxidation, in the development of vascular
disease.
REPRESENTATIVE PUBLICATIONS
Chang
MY, Sasahara M, Chait A, Raines EW, and Ross R: Inhibition of
hypercholesterolemia-induced atherosclerosis in the nonhuman primate
by probucol. II. Cellular composition and proliferation. Arterioscler Thromb Vasc Biol 15:1631-1640, 1995.
Chang
MY, Olin KL, Tsoi C, Wight TN, and Chait A: Human
monocyte-derived macrophages secrete two forms of
proteoglycan-macrophage colony stimulating factor (PG-MCSF) that
differ in their ability to bind low density lipoproteins. J Biol
Chem 273:15985-15992, 1998.
Chang
MY, Potter-Perigo S, Tsoi C, Chait A, and Wight TN: Oxidized low
density lipoproteins regulate synthesis of monkey aortic smooth muscle
cell proteoglycans that have enhanced native low density
lipoprotein-binding properties. J Biol Chem 275:4766-4773, 2000.
Chang MY, Potter-Perigo S, Wight TN, and Chait A:
Oxidized low density lipoproteins bind to non-proteoglycan
components of smooth muscle extracellular matrices. J Lipid Res
42:824-833, 2001.
Chang MY, Tsoi C, Wight TN, Chait A:
Lysophosphatidylcholine regulates synthesis of biglycan and the
proteoglycan form of macrophage colony stimulating factor.
Arterioscler Thromb Vasc Biol 23:809-815, 2003.
Chang MY, Han CY, Wight TN, Chait A: Antioxidants inhibit the
ability of lysophosphatidylcholine to regulate proteoglycan synthesis.
Arterioscler Thromb Vasc Biol 26(3):494-500, 2006.
|